Optibrium Secures Venture Debt from Shawbrook with Mishcon de Reya's Guidance
Deal News | Jul 22, 2025 | Mishcon
Optibrium Limited, a company specializing in software for drug discovery, has secured a multi-million-pound financing package from Shawbrook. The deal, advised by Mishcon de Reya, is aimed at enhancing Optibrium's offerings to global pharmaceutical and biotech teams. Optibrium's software solutions are used by over 160 organizations worldwide to improve the design and optimization of small molecules. Mishcon de Reya's Corporate Innovation and Venture Capital team, including Patrick Neall, advised on the transaction. This funding is expected to boost the speed and efficiency of Optibrium's drug discovery processes.
Sectors
- Pharmaceuticals
- Financial Services
- Software
Geography
- United Kingdom – Optibrium and Mishcon de Reya are both based in the UK, as well as Shawbrook, indicating the primary geography of the transaction.
Industry
- Pharmaceuticals – The article discusses Optibrium's focus on drug discovery, serving pharmaceutical companies with software solutions.
- Financial Services – The financing package from Shawbrook signifies involvement from the financial industry, providing venture debt to Optibrium.
- Software – Optibrium offers software solutions designed for drug discovery, positioned at the intersection of technology and pharmaceuticals.
Financials
- Multi-million-pound – The size of the financing package provided to Optibrium by Shawbrook, although the exact value is not specified.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Optibrium Limited | Target | Company | A company specializing in software solutions for drug discovery, collaborating with global pharmaceutical teams. |
| Mishcon de Reya | Legal Advisor | Company | A law firm advising Optibrium on its venture debt financing from Shawbrook. |
| Shawbrook | Funder | Company | A UK-based bank providing the multi-million-pound financing package to Optibrium. |
| Patrick Neall | Supporting Legal Advisor | Person | Part of Mishcon de Reya's Corporate Innovation and Venture Capital team advising on the deal. |